The Flint Capital fund, managed by Dmitry Smirnov, invested $15 million in Quantori, an American biotech software developer from Russia. The company’s valuation after the round was $100 million.

Flint Capital invested $15 million in the American company Quantori for immigrants from Russia

The deal is reported by TechCrunch and listed on the Quantori card on Crunchbase. According to the service, these are the first funds raised by the company.

Quantori develops software for biotechnological and pharmaceutical projects. One of the company’s solutions is a data platform used to create medicines. Quantori’s clients include Pfizer, Biogen, AstraZeneca, among others.

Headquartered in Boston, USA, Quantori employs more than 700 people. According to open sources, he has an office in St. Petersburg. The company was founded in 2020 by Richard Golob, Yuri Gankin and Vitaly Aronov.


Kirill Bilyk

Source: RB

Previous articlePowerful, practical and versatile handheld vacuum cleaner with MIUI.
Next articleEverything indicates the new iPad will arrive today
I am Bret Jackson, a professional journalist and author for Gadget Onus, where I specialize in writing about the gaming industry. With over 6 years of experience in my field, I have built up an extensive portfolio that ranges from reviews to interviews with top figures within the industry. My work has been featured on various news sites, providing readers with insightful analysis regarding the current state of gaming culture.


Please enter your comment!
Please enter your name here